Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
134 Cards in this Set
- Front
- Back
Bupropion (mechanism, use, toxicity)
|
Increases NE and dopamine; used for smoking sensation, depression; seizures
|
|
Mirtazapine (mechanism, use, toxicity)
|
Alpha-2 antagonist, increases NE and serotonin release, and serotonin receptor agonist; used for depression; sedation, increased appetite with weight gain;
|
|
Maprotiline (mechanism, use, toxicity)
|
Blocks NE reuptake; used for depression; sedation, hypotension
|
|
Trazodone (mechanism, use, toxicity)
|
Inhibits serotonin uptake; used for insomnia; pripism
|
|
Mannitol (mechanism, use, toxicity)
|
Osmotic diuretic; used to treat drug overdose and increased ICP; pulmonary edema, CHF
|
|
Acetazolamide (mechanism, use, toxicity)
|
Carbonic anhydrase inhibitor; used for glaucoma, metabolic alklalosis; hyperchloremic metabolic acidosis, ammonia toxicity, sulfa allergy
|
|
Furosemide (mechanism, use, toxicity)
|
Inhibits NKCC channel, preventing urine concentration; used in hypertension, CHF, hypercalcemia; ototoxicity, hypokalemia, hypocalcemia, nephritis, gout, sulfa allergy
|
|
Ethacrynic acid (mechanism, use, toxicity)
|
Inhibits NKCC channel; used in patients with furosemide (sulfa) allergy; hyperuricemia
|
|
Hydrochlorothiazide (mechanism, use, toxicity)
|
Inhibits NaCl reabsorption in DCT and increases Ca reabsorption; hypertension and hypercalcinuria; hyperglycemia, hyperlipidemia, hyperuricemia, hypercalcemia, sulfa allergy
|
|
Spironolactone, eplerenone (mechanism, use, toxicity)
|
Aldosterone receptor antagonists; hyperaldosteronism, CHF, hypokalemia; hyperkalemia (arrhythmias), antiandrogen effects with spironolactone
|
|
Triamterene, amiloride (mechanism, use, toxicity)
|
Block sodium channels in cortical collecting duct; hyperaldosteronism, CHF
|
|
Captopril, enalapril, lisinopril (mechanism, use, toxicity)
|
ACE inhibitor, leads to reduced angiotensin II levels and decreases GFR; prevents heart remodeling, hypertension, CHF; cough, angioedema, transient creatinine increase, hyperkalemia
|
|
Losartan, valsartan (mechanism, use, toxicity)
|
Angiotensin II receptor antagonists; similar to ACE inhibitors, but do not cause cough due to normal metabolism of bradykinin
|
|
Leuprolide (mechanism, use, toxicity)
|
GnRH analog that acts as an agonist in pulsatile doses and an antagonist in continuous doses; used as an agonist for infertility and an antagonist for prostate cancer, fibroids, and precocious puberty; antiandrogenic
|
|
Finasteride (mechanism, use, toxicity)
|
5-alpha reductase inhibitor; used for BPH and male-pattern baldness
|
|
Flutamide (mechanism, use, toxicity)
|
Testosterone receptor antagonist; used in prostate cancer
|
|
Ketoconazole (mechanism, use, toxicity)
|
Inhibits 17,20-desmolase, stopping sex steroid synthesis; used to treat polycystic ovarian syndrome
|
|
Clomiphene (mechanism, use, toxicity)
|
Partial estrogen agonist in the hypothalamus, increases release of LH and FSH, stimulating ovulation; used for infertility and PCOS
|
|
Tamoxifen (mechanism, use, toxicity)
|
Estrogen receptor antagonist at the breast; used for breast cancer; partial agonist at the uterus, can cause endometrial hyperplasia
|
|
Raloxifene (mechanism, use, toxicity)
|
Estrogen receptor agonist at bone, inhibits osteoclast activity and stimulates osteoblast activity; used to treat osteoporosis
|
|
Anastrozole, exemestane (mechanism, use, toxicity)
|
Aromatase inhibitors; used in breast cancer
|
|
Mifepristone (mechanism, use, toxicity)
|
Progesterone receptor antagonist, given with misoprostol for abortion; abortifacient; bleeding, abdominal pain
|
|
Terbutaline (mechanism, use, toxicity)
|
Beta-2 agonist, inhibits uterine contractions
|
|
Tamsulosin (mechanism, use, toxicity)
|
Alpha-1 antagonist; used to treat BPH
|
|
Sildenafil, vardenafil (mechanism, use, toxicity)
|
Phosphodiesterase 5 inhibitors, causing inc. cGMP levels and smooth muscle relaxation; used in erectile dysfunction; impaired blue-green vision, contradindicated with nitrates
|
|
Danazol (mechanism, use, toxicity)
|
Partial androgen receptor agonist; used to treat endometriosis and hereditary angioedema; weight gain, acne, hirsutism, low HDL, hepatoxicity
|
|
Treat methemoglobinemia with
|
Methylene blue
|
|
Diphenhydramine, dimenhydrinate, chlorpheniramine (mechanism, use, toxicity)
|
(First generation) H1 antagonists; used in allergies, motion sickness, insomnia; sedation, antiadrenergic, antiserotonergic, and antimuscarinic effects due to CNS penetration
|
|
Loratadine, fexofenadine, desloratadine, cetrizine (mechanism, use, toxicity)
|
H1 antagonists, 2nd gen; used in allergies; less fatigue than 1st gen antihistamines due to decreased CNS penetration
|
|
Albuterol (mechanism, use, toxicity)
|
Short-acting beta-2 agonist; asthma
|
|
Salmeterol, formoterol (mechanism, use, toxicity)
|
Long-acting beta-2 agonist; asthma; tremor, arrhythmias
|
|
Theophylline (mechanism, use, toxicity)
|
Phosphodiesterase inhibitor, increases cAMP and causes bronchodilation; asthma; cardiotoxicity, neurotoxicity
|
|
Ipratropium (mechanism, use, toxicity)
|
Muscarinic antagonist, prevents bronchoconstriction; asthma and COPD
|
|
Beclomethasone, fluticasone (mechanism, use, toxicity)
|
Inhibit cytokine synthesis, reducing inflammation due to asthma; 1st line for chronic asthma
|
|
Montelukast, zafirlukast (mechanism, use, toxicity)
|
Leukotriene receptor antagonists; especially useful in aspirin-induced asthma
|
|
Zileuton (mechanism, use, toxicity)
|
Inhibits activity of 5-lipoxygenase, inhibiting leukotriene production; reduces inflammation
|
|
Omalizumab (mechanism, use, toxicity)
|
Anti-IgE antibody; used in refractory allergic asthma
|
|
Guaifenesin (mechanism, use, toxicity)
|
Thins respiratory secretions
|
|
N-acetylcysteine (mechanism, use, toxicity)
|
Loosens mucus plugs; used in CF patients and as an antidote to acetominaphen posioning
|
|
Bosentan (mechanism, use, toxicity)
|
Antagonizes endothelin-1 receptors, reducing vascular resistance in the pulmonary vessels; used in pulmonary hypertension
|
|
Dextromethorphan (mechanism, use, toxicity)
|
Antagonizes NMDA receptors, inhibiting coughing; produces opioid effects in large doses and carries mild abuse potential
|
|
Pseudoephedrine, phenylephrine (mechanism, use, toxicity)
|
Alpha-1 agonists that reduce edema and nasal congestion; rhinitis; hypertension, quick tolerance (recurrence of symptoms despite continued treatment)
|
|
Difference in competitive vs noncompetitve inhibitors?
|
competitive = decrease potency, noncompetitive = decrease efficacy.
|
|
What is Km?
|
Inverse relation of affinity of enzyme for its substrate.
|
|
What is Vmax?
|
Direct proportion to enzyme concentration
|
|
What is bioavailability?
|
Fraction of administered drug that reaches systemic circulation unchanged.
|
|
Time to steady state depends on?
|
depends on half-life. Does not depend on frequency or size of dose.
|
|
What is rate of elimination in zero order kinetics?
|
constant amount eliminated per time.
|
|
Give three drugs that are zero order eliminated.
|
PEA - phenytoin, Ethanol, Aspirin.
|
|
What is the rate of elimination for first order kinetics?
|
A constant FRACTION is eliminted, variable by concentration!
|
|
How does ionization relate to urine pH?
|
Ionzied species are trapped in urine and not resorbed. Neutral can be resorbed.
|
|
How do you treat overdose of weak acid? Give drug examples.
|
Treat with Bicarb to make neutral. Exp: phenobarbital, methotrexate, aspirin.
|
|
How do you treat overdose of weak base? Give drug examples.
|
Treat with ammonium chloride. exp: amphetamines.
|
|
What is phase I drug metabolism? What pt. population loses this?
|
Reduction, Oxidation, hydrolysis with CYP450. Often gives neutral products. Geriatrics lose this phase.
|
|
What is phase II metaboloism? What population depend on this?
|
Conjugation (Glucuronidation, Acetylation, and Sulfation.) Gives charged products. Geriatrics depend on this, old people have GAS.
|
|
What is efficacy?
|
maximal effect a drug can produce.
|
|
What is potency?
|
amount of drug needed for the same effect.
|
|
What happends to efficacy when a partial agonist and full agonist are mixed?
|
DECREASED efficacy. fight for same binding site, full agonist cant exert full effect.
|
|
What is therapetuic index?
|
LD50/ED50. Median lethal dose divded by median effective dose. Safer drugs have a higher TI.
|
|
What is a therapeutic window?
|
Minimum effective dose to minimum toxic dose. Think of it as range of use.
|
|
What are the two types of Nicotonic receptors? What kind of messenger do they use?
|
1. Nicotinic - Ligang gated Na/K channels. Two nicotinic types: Nm(NMJ) and Nn(autonomic ganglia. 2. Muscarinic - G-proteins. 5 types, M1-M5.
|
|
Alpha-1 sympathetic receptor (G-protein class, major function)
|
q, increase: vasc. smooth muscle contraction, pupillary dilator muscle contraction, intestinal and bladder sphincter contaction.
|
|
Alpha-2 sympathetic receptor(G-protein class, major function)
|
i, decrease: sympathetic outflow, insulin release, lipolysis. increase: platlet aggregation.
|
|
Beta-1 sympathetic receptor(G-protein class, major function)
|
s, increase: heart rate, contractilty, renin release, lipolysis
|
|
Beta-2 sympathetic receptor(G-protein class, major function)
|
s, vasodilation, brochodilation, increase: heart rate, contractility, lipolysis, insulin release, aqueous humor production. decrease: uterine tone, ciliary muscle tone.
|
|
M-1 Parasymp receptor(G-protein class, major function)
|
q, CNS, enteric nervouse system.
|
|
M-2 Parasymp(G-protein class, major function)
|
i, decease: heart rate, contractility of atria
|
|
M-3 parasymp(G-protein class, major function)
|
increase: exocrine gland secretion (tears, gastric, etc), gut peristalsis, bladder contraction, bronchoconstriction, pupillary spinchter contraction, cilliary muscle contraction.
|
|
What receptor is responsible for miosis and accomodation?
|
Parasympathetic M-3.
|
|
What receptor is responsbile for mydriasis?
|
Sympathetic Alpha-1.
|
|
Dopamine D-1 receptor(G-protein class, major function)
|
s, relaxes renal vascular smooth muscle
|
|
Dopamine D-2 receptor(G-protein class, major function)
|
i, modulates transmitter release especially in brain.
|
|
Histamine H-1 receptor(G-protein class, major function)
|
q, increase: mucus production, contraction of bronchioles, pruritus, pain.
|
|
histamine H-2 receptor(G-protein class, major function)
|
a, increase gastric acid secretion
|
|
vasopression V-1 receptor(G-protein class, major function)
|
q, increase: vascular smooth muscle contraction
|
|
vasopression V-2 receptor(G-protein class, major function)
|
s, increase water permeability and reabsorption in kidneys. (V2 found in 2 kidneys).
|
|
Which receptors work via Gq -> Phospholipase C ->Pip2->DAG + IP3?
|
H1,Alpha1,V1,M1,M3. (remember HAVe 1 M&M)
|
|
DAG causes activation of what?
|
Protein Kinase C.
|
|
IP3 causes increase in what?
|
Calcium -> smouth muscle contraction
|
|
Which receptors work via Gi->Adenyly cyclase ->cAMP ->Protein Kinase A?
|
M2, Alpha2, D2. (remember MAD 2's.)
|
|
Which receptors work via Gs->adenylyate cyclase ->cAMP->Protein Kinase A?
|
Beta1, Beta2, D1, H2,V2.
|
|
What does protein kinase A do?
|
increase calcium release in heart and blocks myosin light chain kinase.
|
|
What are the two classes of cholinomimetics?
|
1. direct agonsts 2. indirect agonists (anticholinesterases).
|
|
Bethanechol(mechanism,use,toxicity)
|
Direct cholinomimetic. Postop or neurogenic ileus, urinary retention. COPD+asthma exacerbation, peptic ulcers.
|
|
Carbachol(mechanism,use,toxicity)
|
Direct Cholinomimetic. Identical to Ach. Glaucoma, pupillary contraction, relief of IOP. COPD+asthma exacerbation, peptic ulcers.
|
|
Pilocarpine(mechanism,use,toxicity)
|
Direct Cholinomimetic. Stimulates tears, salvia, sweat. Open and closed-angle glaucoma.COPD+asthma exacerbation, peptic ulcers.
|
|
methacholine(mechanism,use,toxicity)
|
Direct Cholinomimetic. challenge test of asthma diagnosis. COPD+asthma exacerbation, peptic ulcers.
|
|
Neostigmine(mechanism,use,toxicity)
|
Indirect cholinomimetic agonist. NO cns penetration. Postop and neurogenic ileus, myasthenia gravis, reversal of NMJ block. COPD+asthma exacerbation, peptic ulcers.
|
|
pyridostigmine(mechanism,use,toxicity)
|
indirect cholinomimetic agonist. Long acting myasthenia gravis treatment. COPD+asthma exacerbation, peptic ulcers.
|
|
edrophonium(mechanism,use,toxicity)
|
indirect cholinomimetic agonist. Short acting, for myasthenia gravis diagnosis. COPD+asthma exacerbation, peptic ulcers.
|
|
Physostigmine(mechanism,use,toxicity)
|
indirect cholinomimetic agonist. for anti-cholinergic overdose, crosses BBB. COPD+asthma exacerbation, peptic ulcers.
|
|
Donepezil(mechanism,use,toxicity)
|
indirect cholinomimetic agonist. Alzheimers disease. COPD+asthma exacerbation, peptic ulcers.
|
|
signs of cholinesterase inhibitor poisoning. treatment.
|
DUMBBELSS (diarrhea, urination, miosis, bronchospasm, bradycardia, excitation of skeletal muscle +CNS, lacrimation, sweating, salvia.) tx: atropine + pralidoxime.
|
|
Parathion(mechanism, treatment)
|
Irreversible cholinesterase inhibitor, ACH overdose. Tx: atropine + pralidoxime.
|
|
Atropine, homatropine, tropicamide (mechanism, use, toxicity).
|
Muscarinic antagonist. produces mydriasis and cycloplegia. (Atropine also used for bradycardia). Causes hot as a hare, dry as bone, red as beet, blind as bat, mad as a hatter.
|
|
Benztropine(mechanism,use,toxicity)
|
Muscarinic antagoist. Parkinsons disease (park my benz). Can be used in haloperiodal O.D, whihc causes torticolliosis. Causes hot as a hare, dry as bone, red as a beet, blind as a bat, mad as a hatter.
|
|
Scopolamine(mechanism,use,toxicity)
|
Muscarinic antagonist. Motion sickness. causes hot as a hare, dry as a cone, red as a beet, blind as a bat, mad as a hatter.
|
|
Ipratropium,tiotropium (mechanism, use, toxicity)
|
Muscarinic antagonist. COPD, Asthma. Causes hot as a hare, dry as a bone, red as a beet, blind as a bat, mad as a hatter.
|
|
Oxybutynin(mechanism,use,toxicity)
|
Muscarinic anatagonist. reduces urgency in mild cystitis and reduce bladder spasms. causes hot as a hare, dry as a bone, red as a beet, blind as a bat, mad as a hatter.
|
|
Glycopyrrolate(mechanism,use,toxicity)
|
Muscarinic anatagonist. IP: given in preop to reduce airway secretions. oral:reduce drooling, peptic ulcer. Can cause hot as a hare, dry as a bone red as a beet, blind as a bat, mad as a hatter.
|
|
Jimson Weed(mechanism, toxicity)
|
muscarinic antagonist, causes gardner's pupil (mydriasis).
|
|
Epinephrine(Mechanism, receptors bound, use, toxicity)
|
Direct Sympathomemetic. A1,A2,B1,B2. Anaphylaxis, open angle glaucoma, asthma, hypotension.
|
|
Norepinephine(Mechanism, receptors bound, use, toxicity)
|
direct sympathomemetic. A1,A2, some B1. used in hypotension but it decrease renal perfusion.
|
|
Isoproterenol(Mechanism, receptors bound, use, toxicity)
|
Direct sympathomemetic. B1, B2. Used in Torsade de pointe and bradyarryhmia. Can cause tachycardia and worsen cardiac ischemia.
|
|
dopamine(Mechanism, receptors bound, use, toxicity)
|
Direct sympathomimetics. Receptors depend on dose. low = D1, med = D1,B2,B1, high = A1,A2,B1,B2,D1. Used in shock and heart failure (ionotropic and chronotropic).
|
|
dobutamine(Mechanism, receptors bound, use, toxicity)
|
Direct sympathomimetic. Mostly B1, little a1,a2,b2. Used in heart failure and cardiac stresstest (ionotrpic and chronotropic)
|
|
Phenylephrine(Mechanism, receptors bound, use, toxicity)
|
Direct sympathomimetic. A1, A2. Used in hypotension, to cause mydriasis, and rhinitis (decongestant).
|
|
Albuterol, salmetrol, terbutaline (Mechanism, receptors bound, use, toxicity)
|
Direct sympathomimetic. Mostly B2, some b1. Sal = long term ashtma or copd. Albuterol for short term asthma. Terbutaline for to reduce premture uterine contractions.
|
|
Ritodrine(Mechanism, receptors bound, use, toxicity)
|
Direct sympathomimetic. B2 only. Used to reduce premature uterine contractions.
|
|
Amphetamine (mechanism, use)
|
indirect sympathomimetic. Releases stored catecholamines. Used for narcolepsy, obesity, ADD.
|
|
Epinephrine(Mechanism, use, toxicity)
|
indirect sympathomimetic. Releases stored catecholamines. Used for nasal decongestion, urinary incontience, hypotension.
|
|
Cocaine (mechanims, use).
|
direct sympathomimetic. Reuptake inhibitor. Causes vasoconstriction and local anesthesia.
|
|
Why must B-Blockers be avoided in suspected cocaine intoxication?
|
mixing them can lead to unopposed A1 activation and extreme hypertenion.
|
|
How does norepinephrine cause reflex bradycardia?
|
stimulates A1>B2. Causes increased vasoconstrciton -> increased BP. This causes reflex bradycardia and slowing of HR.
|
|
How does isoproterenol cause reflex tachycardia?
|
Stimulates B2>A1. This cause vasodilation and dropping of BP. B1 is stimulated and causes tachycardia.
|
|
Clonidine, alpha-methyldopa(Mechanism, receptors bound, use)
|
Centrally acting alpha-2 agonists, this causes LESS peripheral sympathetic release.Used in hypertension, especially renal disease due to no increase in renal blood flow!
|
|
Phenoxybenzamine(Mechanism, receptors bound, use, toxicity)
|
IRREVERSIBLE nonslective alpha blocker. Used in pheochromosytoma BEFORE surgery! toxic: orhtostatic hypotension, reflec tachycardia.
|
|
phentolamine(Mechanism, receptors bound, use, toxicity)
|
REVERSBILE nonselective alpha blocker. give to patients on MAOI who each tyramine contraining foods.
|
|
Prazosin, Terazosin, Doxazosin,Tamsulosin(Mechanism, receptors bound, use, toxicity)
|
Alpha-1 blocker. Used in hypertension, urinary rentention in BPH. tox:orthostatic hypotension, dizziness, headache.
|
|
Mirtazapine (mechanism, use, toxicity)
|
Alpha-2 blocker. Used in depression. tox: sedation, hypercholesterolemia, increased apetite.
|
|
Describe what occurs when you alpha-blockade epi vs. phenylephrine.
|
Before blockade: Both epi and phen RAISES BP. After alpha blockade: only epi raises, no change in phenyl. Why: Epi has B binding, phenyl does NOT.
|
|
Give 6 applications of Beta-blockers in general.
|
Angina - decreases HR and contractility, decreasing oxygen use. MI - decrease mortality. SVT - decrease AV duction. Hypertension - decrease CO and renin secretion. CHF - slows progression. Glaucoma - decrease secretion of aqueous humor.
|
|
give general toxicites of b-blockers
|
impotence, asthma exacerbation, bradycardia, seizures, sedation, hides hypoglycemia.
|
|
What are the B1 selective b-blockers? When are they useful?
|
A BEAM. acebutolol, betaxolol, Esmolol, Atenolol, Metoprolol. Useful in comorbid pum. disease.
|
|
What are the nonselective ( b1 = b2) b-blockers?
|
Please Try Not Being Picky. Propranolol, Timolol, Nadolol, Pindolol. B = B-blocker.
|
|
what are the nonselective a and b-antagonists?
|
Carvedilol, labetalol.
|
|
What are the partial B-agonists?
|
Pindolol, Acebutolol.
|
|
Give treatment for acetaminophen overdose.
|
N-Acetylcysteine (replenishes glutathione).
|
|
Give treatment for salicylates overdose.
|
NaHCO3 (alkalinize urine)
|
|
give treatment for amphetamines overdose
|
NH4Cl (acidify urine)
|
|
Give treatment for antimuscarinic and anticholinergic overdose.
|
Phygostigmine and control the hyperhermia.
|
|
Give treatment for b-blocker overdose
|
Glucagon
|
|
Give treatment for digitalis overdose
|
(KLAM) normalize K, Lidocaine, Anti-dig fab fragments, Mg2
|
|
give treatment for iron overdose.
|
deFEroxamine, deFErasirox.
|